Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurodevelopmental Impact of Treatment in Hypothyroxinaemia of Prematurity.

NCT06346236 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT06346236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06346236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurodevelopmental Impact of Treatment in Hypothyroxinaemia of Prematurity.
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
September 1, 2022
Enrollment
373 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

transient hypothyroxinemia of prematurity